2021 Q3 Form 10-Q Financial Statement

#000121390021054196 Filed on October 22, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3
Revenue $4.172M $4.170M
YoY Change 0.05% -21.02%
Cost Of Revenue $2.673M $3.440M
YoY Change -22.3% -8.27%
Gross Profit $1.499M $740.0K
YoY Change 102.57% -51.63%
Gross Profit Margin 35.93% 17.75%
Selling, General & Admin $1.542M $1.820M
YoY Change -15.27% -7.61%
% of Gross Profit 102.87% 245.95%
Research & Development $660.0K $600.0K
YoY Change 10.0% -29.41%
% of Gross Profit 44.03% 81.08%
Depreciation & Amortization $82.00K $80.00K
YoY Change 2.5% -20.0%
% of Gross Profit 5.47% 10.81%
Operating Expenses $2.202M $2.410M
YoY Change -8.63% -14.23%
Operating Profit -$703.0K -$1.670M
YoY Change -57.9% 30.47%
Interest Expense -$117.0K -$110.0K
YoY Change 6.36% 120.0%
% of Operating Profit
Other Income/Expense, Net $619.0K
YoY Change
Pretax Income -$201.0K -$1.790M
YoY Change -88.77% 34.59%
Income Tax
% Of Pretax Income
Net Earnings -$201.0K -$1.790M
YoY Change -88.77% 34.59%
Net Earnings / Revenue -4.82% -42.93%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$16.44K -$0.18
COMMON SHARES
Basic Shares Outstanding 12.23M shares
Diluted Shares Outstanding 12.23M shares

Balance Sheet

Concept 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $271.0K $80.00K
YoY Change 238.75% -78.38%
Cash & Equivalents $271.0K
Short-Term Investments
Other Short-Term Assets $1.517M $880.0K
YoY Change 72.39% -10.2%
Inventory $4.081M $5.240M
Prepaid Expenses
Receivables $1.770M $2.010M
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.639M $8.200M
YoY Change -6.84% -32.12%
LONG-TERM ASSETS
Property, Plant & Equipment $2.481M $3.040M
YoY Change -18.39% -23.04%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $690.0K $820.0K
YoY Change -15.85% 0.0%
Total Long-Term Assets $4.491M $5.340M
YoY Change -15.9% -16.82%
TOTAL ASSETS
Total Short-Term Assets $7.639M $8.200M
Total Long-Term Assets $4.491M $5.340M
Total Assets $12.13M $13.54M
YoY Change -10.41% -26.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.149M $2.720M
YoY Change -20.99% 6.25%
Accrued Expenses $1.342M $1.560M
YoY Change -13.97% 23.81%
Deferred Revenue
YoY Change
Short-Term Debt $2.058M $1.880M
YoY Change 9.47% 135.0%
Long-Term Debt Due $71.00K $30.00K
YoY Change 136.67% 0.0%
Total Short-Term Liabilities $5.640M $6.210M
YoY Change -9.18% 32.98%
LONG-TERM LIABILITIES
Long-Term Debt $1.530M $2.750M
YoY Change -44.36% 5400.0%
Other Long-Term Liabilities $1.205M $1.970M
YoY Change -38.83% -28.88%
Total Long-Term Liabilities $2.735M $4.720M
YoY Change -42.06% 67.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.640M $6.210M
Total Long-Term Liabilities $2.735M $4.720M
Total Liabilities $8.375M $10.92M
YoY Change -23.31% 45.79%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.755M $2.610M
YoY Change
Total Liabilities & Shareholders Equity $12.13M $13.54M
YoY Change -10.41% -26.81%

Cashflow Statement

Concept 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$201.0K -$1.790M
YoY Change -88.77% 34.59%
Depreciation, Depletion And Amortization $82.00K $80.00K
YoY Change 2.5% -20.0%
Cash From Operating Activities -$753.0K -$120.0K
YoY Change 527.5% -80.65%
INVESTING ACTIVITIES
Capital Expenditures -$4.000K $10.00K
YoY Change -140.0% -94.12%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$4.000K -$10.00K
YoY Change -60.0% -94.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 684.0K -250.0K
YoY Change -373.6% -126.32%
NET CHANGE
Cash From Operating Activities -753.0K -120.0K
Cash From Investing Activities -4.000K -10.00K
Cash From Financing Activities 684.0K -250.0K
Net Change In Cash -73.00K -380.0K
YoY Change -80.79% -337.5%
FREE CASH FLOW
Cash From Operating Activities -$753.0K -$120.0K
Capital Expenditures -$4.000K $10.00K
Free Cash Flow -$749.0K -$130.0K
YoY Change 476.15% -83.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
BLONDER TONGUE LABORATORIES INC
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
dei Entity Central Index Key
EntityCentralIndexKey
0001000683
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
USD
bdr Gain On Debt Forgiveness
GainOnDebtForgiveness
USD
bdr Amortization Of Subordinated Debt Discount
AmortizationOfSubordinatedDebtDiscount
USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
USD
bdr Disposition Of Right Of Use Assets
DispositionOfRightOfUseAssets
USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
bdr Conversion Of Subordinated Convertible Debt To Common Stock
ConversionOfSubordinatedConvertibleDebtToCommonStock
USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
USD
CY2020Q4 bdr Capital Lease Future Minimum Payments Due Thereafter
CapitalLeaseFutureMinimumPaymentsDueThereafter
USD

Files In Submission

Name View Source Status
0001213900-21-054196-index-headers.html Edgar Link pending
0001213900-21-054196-index.html Edgar Link pending
0001213900-21-054196.txt Edgar Link pending
0001213900-21-054196-xbrl.zip Edgar Link pending
bdr-20210930.xsd Edgar Link pending
bdr-20210930_cal.xml Edgar Link unprocessable
bdr-20210930_def.xml Edgar Link unprocessable
bdr-20210930_lab.xml Edgar Link unprocessable
bdr-20210930_pre.xml Edgar Link unprocessable
f10q0921ex31-1_blonder.htm Edgar Link pending
f10q0921ex31-2_blonder.htm Edgar Link pending
f10q0921ex32-1_blonder.htm Edgar Link pending
f10q0921_blondertongue.htm Edgar Link pending
f10q0921_blondertongue_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending